NO965564D0 - Medical application of bromelain - Google Patents

Medical application of bromelain

Info

Publication number: NO965564D0
Authority: NO; Norway
Prior art keywords: bromelain; medical application; medical; application
Prior art date: 1994-06-24

Application number

NO965564A

Other languages

Norwegian (no)

Other versions

NO965564L (en

Inventor

Tracey Lehanne Mynott

Christian Engwerda

Original Assignee

Cortecs Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-06-24

Filing date

1996-12-23

Publication date

1996-12-23

1996-12-23 Application filed by Cortecs Ltd filed Critical Cortecs Ltd

1996-12-23 Publication of NO965564D0 publication Critical patent/NO965564D0/en

1997-02-24 Publication of NO965564L publication Critical patent/NO965564L/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Neurology (AREA)
Communicable Diseases (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Oncology (AREA)
Tropical Medicine & Parasitology (AREA)
Neurosurgery (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Saccharide Compounds (AREA)

NO965564A 1994-06-24 1996-12-23 Medical application of bromelain NO965564L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB9412711A GB9412711D0 (en)	1994-06-24	1994-06-24	Medical use of bromelain
PCT/GB1995/001501 WO1996000082A1 (en)	1994-06-24	1995-06-26	Medical use of bromelain

Publications (2)

Publication Number	Publication Date
NO965564D0 true NO965564D0 (en)	1996-12-23
NO965564L NO965564L (en)	1997-02-24

Family

ID=10757263

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO965564A NO965564L (en)	1994-06-24	1996-12-23	Medical application of bromelain

Country Status (13)

Country	Link
EP (1)	EP0766565A1 (en)
JP (1)	JPH10502073A (en)
KR (1)	KR970703784A (en)
CN (1)	CN1151119A (en)
AU (1)	AU2749395A (en)
CA (1)	CA2193654A1 (en)
FI (1)	FI965204L (en)
GB (1)	GB9412711D0 (en)
IL (1)	IL114331A0 (en)
NO (1)	NO965564L (en)
TW (1)	TW403654B (en)
WO (1)	WO1996000082A1 (en)
ZA (1)	ZA955292B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9526691D0 (en) *	1995-12-29	1996-02-28	Cortecs Ltd	Medical use of proteases
US20020102253A1 (en) *	1997-02-25	2002-08-01	Mynott Tracey Lehanne	Component of bromelain
ATE533842T1 (en) *	1997-02-25	2011-12-15	Sarantis Pty Ltd	BROMELAIN COMPONENT
WO1998038320A1 (en)	1997-02-25	1998-09-03	Cortecs (Uk) Limited	Component of bromelain
NO304766B1 (en)	1997-06-16	1999-02-08	Sintef	fingerprint Sensor
DE19726254C2 (en) *	1997-06-20	1999-10-21	Mucos Pharma Gmbh & Co	Tolerance induction through proteases
DE19726248C2 (en) *	1997-06-20	2000-03-02	Mucos Pharma Gmbh & Co	Use of proteolytic enzymes and rutoside to treat septic shock
DE19726244C2 (en) *	1997-06-20	2000-03-02	Mucos Pharma Gmbh & Co	Use of proteolytic enzymes and rutoside to prevent or treat graft rejection
DE19726255C2 (en) *	1997-06-20	2000-03-16	Mucos Pharma Gmbh & Co	Influence of cytokines by proteolytic enzymes and rutoside
GB9713667D0 (en) *	1997-06-27	1997-09-03	Cortecs Ltd	Enhancement of intestinal permeability
GB9819138D0 (en) *	1998-09-02	1998-10-28	Cortecs Uk Ltd	Nucleic acids and proteins from pineapple stem
GB9819137D0 (en) *	1998-09-02	1998-10-28	Cortecs Uk Ltd	Component of bromelain
DE19847114A1 (en) *	1998-10-13	2000-04-20	Mucos Pharma Gmbh & Co	Use of proteolytic enzymes to modulate hyperactive T cells, especially for symptomatic treatment of immune-mediated inflammatory diseases, e.g. multiple sclerosis, diabetes, arthritis or glomerulonephritis
CA2346448A1 (en) *	1998-12-16	2000-06-22	Warner-Lambert Company	Treatment of arthritis with mek inhibitors
DE19957318A1 (en) *	1999-11-29	2001-06-21	Mucos Pharma Gmbh & Co	Influence of TGF-beta by proteolytic enzymes
DE10018980A1 (en) *	2000-04-17	2001-11-08	Mucos Pharma Gmbh & Co	Prophylaxis and therapy of diabetes mellitus I using proteolytic enzymes
EP1208849B1 (en) *	2000-11-28	2015-10-28	URSAPHARM Arzneimittel GmbH	Use of bromelain for adjuvant therapy during wound healing process
TW201419131A (en)	2012-11-09	2014-05-16	Health & Life Co Ltd	Voice-assisted biomedical sensing apparatus
US9526768B2 (en) *	2014-11-13	2016-12-27	Jennifer Mai	Compositions for the treatment of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS59225122A (en) *	1983-05-23	1984-12-18	Kaken Pharmaceut Co Ltd	Cachexia treatment improver
ES2072280T3 (en) *	1989-10-06	1995-07-16	Mucos Emulsions Gmbh	CATABOLIC ENZYMES FOR THE INDUCTION OF THE TUMOR NECROSIS FACTOR (TNF).
DE4302060A1 (en) *	1993-01-26	1994-07-28	Mucos Pharma Gmbh & Co	Use of bromelain as CD44 surface molecule modifier
GB9313188D0 (en) *	1993-06-25	1993-08-11	Cortecs Ltd	Medical use of enzymes

1994
- 1994-06-24 GB GB9412711A patent/GB9412711D0/en active Pending
1995
- 1995-06-25 IL IL11433195A patent/IL114331A0/en unknown
- 1995-06-26 JP JP8502932A patent/JPH10502073A/en active Pending
- 1995-06-26 AU AU27493/95A patent/AU2749395A/en not_active Abandoned
- 1995-06-26 WO PCT/GB1995/001501 patent/WO1996000082A1/en not_active Ceased
- 1995-06-26 CA CA002193654A patent/CA2193654A1/en not_active Abandoned
- 1995-06-26 FI FI965204A patent/FI965204L/en unknown
- 1995-06-26 KR KR1019960707424A patent/KR970703784A/en not_active Withdrawn
- 1995-06-26 ZA ZA955292A patent/ZA955292B/en unknown
- 1995-06-26 EP EP95922672A patent/EP0766565A1/en not_active Withdrawn
- 1995-06-26 CN CN95193767A patent/CN1151119A/en active Pending
- 1995-07-04 TW TW084106855A patent/TW403654B/en active
1996
- 1996-12-23 NO NO965564A patent/NO965564L/en unknown

Also Published As

Publication number	Publication date
TW403654B (en)	2000-09-01
NO965564L (en)	1997-02-24
JPH10502073A (en)	1998-02-24
CA2193654A1 (en)	1996-01-04
FI965204A7 (en)	1997-02-21
CN1151119A (en)	1997-06-04
KR970703784A (en)	1997-08-09
AU2749395A (en)	1996-01-19
ZA955292B (en)	1997-07-28
GB9412711D0 (en)	1994-08-17
EP0766565A1 (en)	1997-04-09
FI965204A0 (en)	1996-12-23
IL114331A0 (en)	1995-10-31
FI965204L (en)	1997-02-21
WO1996000082A1 (en)	1996-01-04

Publication	Publication Date	Title
FI964339L (en)	1996-10-28	Enzyme treatment of glucans
PT1032396E (en)	2004-06-30	STERILIZATION OF GLUCOCORTICOESTEROIDS
NO965564D0 (en)	1996-12-23	Medical application of bromelain
FI951579A0 (en)	1995-04-03	Connection structure of panellic components
NO963049L (en)	1996-09-23	Modulators of anchoring protein function
NO20001479D0 (en)	2000-03-22	Treatment of behavioral disorder
ID18679A (en)	1998-04-30	USE OF FURTHER THERAPY
EP0996433A4 (en)	2009-05-27	TREATMENT PROCEDURE OF LACTOSYLCERAMIDE-CONDITIONED STATES
FI971750A0 (en)	1997-04-24	Compositions for the treatment of multiple sclerosis and its treatment
KR970000228A (en)	1997-01-21	Oral preparations of S-etodolak
NO955258D0 (en)	1995-12-22	Medical use of enzymes
NO963482D0 (en)	1996-08-21	Medical application of bromelain
FI950389A0 (en)	1995-01-30	New medical products are available
NO931399D0 (en)	1993-04-16	USE OF NATURSTEIN
FI942576A0 (en)	1994-06-01	Behandling of plasma
NO964685L (en)	1997-05-07	Isomization of equilin
NO20000274D0 (en)	2000-01-19	Treatment of fluids
FI940970A0 (en)	1994-03-01	Neutralization of saopa
SE9301995D0 (en)	1993-06-10	NEW MEDICAL APPLICATION
KR960023725U (en)	1996-07-22	Retaining of Trifoot Joint
HK1004195A (en)	1998-11-20	Medical use of bromelain
ID17459A (en)	1998-01-08	ELEMENTS OF TREATMENT
SE9603101D0 (en)	1996-08-28	Medical use of enzyme
NO943793D0 (en)	1994-10-07	New application of
UA644S (en)	1994-12-29	MICRO-EOM OF WIDE PURPOSE